MGRN1 Antibodies

Santa Cruz Biotechnology delivers a wide array of MGRN1 monoclonal antibodies for research focused on understanding MGRN1 protein functions. MGRN1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MGRN1, or Mahogunin Ring Finger 1, is an E3 ubiquitin ligase that plays a critical role in protein degradation and cellular signaling pathways. MGRN1 influences various cellular processes, including apoptosis and immune response mechanisms. Research has shown MGRN1's significance in cancer development and neurodegenerative conditions. Scientists studying MGRN1 continue to uncover new insights about its cellular functions and regulatory mechanisms. Investigating MGRN1 expression and activity patterns helps reveal its potential as a therapeutic target. Current research explores how MGRN1 interacts with other proteins in different cellular pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of MGRN1's role in health and disease.